Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 375Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Feburic

02 6Uloric

PharmaCompass

01

Brand Name : Uloric

Febuxostat

arrow
BioFlorida Conference
Not Confirmed

02

Brand Name : Feburic

Febuxostat

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Feburic

arrow
BioFlorida Conference
Not Confirmed

Febuxostat

Main Therapeutic Indication : Immunology

Currency : USD

2020 Revenue in Millions : 23

2019 Revenue in Millions : 17

Growth (%) : 32

blank

03

Brand Name : Feburic

Febuxostat

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Feburic

arrow
BioFlorida Conference
Not Confirmed

Febuxostat

Main Therapeutic Indication : Immunology

Currency : USD

2021 Revenue in Millions : 24

2020 Revenue in Millions : 23

Growth (%) : 12

blank

04

Brand Name : Uloric

Febuxostat

arrow
BioFlorida Conference
Not Confirmed

05

Brand Name : Uloric

Febuxostat

arrow
BioFlorida Conference
Not Confirmed

06

Brand Name : Feburic

Febuxostat

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Feburic

arrow
BioFlorida Conference
Not Confirmed

Febuxostat

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 26

2021 Revenue in Millions : 24

Growth (%) : 6

blank

07

Brand Name : Feburic

Febuxostat

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Feburic

arrow
BioFlorida Conference
Not Confirmed

Febuxostat

Main Therapeutic Indication : Immunology

Currency : USD

2019 Revenue in Millions : 18

2018 Revenue in Millions : 18

Growth (%) : 0

blank

08

Brand Name : Uloric

Febuxostat

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Uloric

arrow
BioFlorida Conference
Not Confirmed

Febuxostat

Main Therapeutic Indication : Rheumatoid Arthiritis

Currency : USD

2016 Revenue in Millions : 377

2015 Revenue in Millions : 370

Growth (%) : 2

blank

09

Brand Name : Uloric

Febuxostat

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Uloric

arrow
BioFlorida Conference
Not Confirmed

Febuxostat

Main Therapeutic Indication : Rheumatoid Arthritis

Currency : USD

2017 Revenue in Millions : 444

2016 Revenue in Millions : 402

Growth (%) : 10

blank

10

Brand Name : Uloric

Febuxostat

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Uloric

arrow
BioFlorida Conference
Not Confirmed

Febuxostat

Main Therapeutic Indication : Autoimmune Disorders

Currency : USD

2018 Revenue in Millions : 471

2017 Revenue in Millions : 416

Growth (%) : 13%

blank